Project Details
Description
Phase 1b/2a, Randomized, Double-blind Study to Investigate Safety, Tolerability, PK, PD, and Preliminary Efficacy of Oral Administration of SNIPR001 in Patients with Hematologic Malignancy
| Status | Active |
|---|---|
| Effective start/end date | 9/25/24 → 9/24/35 |
Funding
- SNIPR BIOME APS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.